Multibiomarker analysis in patients with acute myocardial infarction
Christiana Schernthaner(Paracelsus Medical University), Daniel Kretzschmar(Friedrich Schiller University Jena), Christian Jung(Heinrich Heine University Düsseldorf), Rudin Pistulli(Friedrich Schiller University Jena), Bernhard Wernly(Paracelsus Medical University), Uta C. Hoppe(Baker Heart and Diabetes Institute), Attila Yilmaz(Friedrich Schiller University Jena), John Pernow(Karolinska Institutet), Elisabeth Haschke‐Becher(Paracelsus Medical University), Michael Lichtenauer(Medical University of Vienna), Ilonka Rohm(Friedrich Schiller University Jena), Janne Cadamuro(Paracelsus Medical University), P. Christian Schulze(Columbia University Irving Medical Center), Hans‐Reiner Figulla(Friedrich Schiller University Jena), Vera Paar(Paracelsus Medical University)
Cited by 90
Related Papers
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial
|The Lancet|2018|734